Invite People

Share 4Engineers with your friends and help them get started!

Emails
Enter multiple email addresses by separating it with a comma.
Back
4Engineers
· Chemical Engineering Online
AI summary

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, has opened an Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea—a €300+ million investment, its largest Life Science spend in APAC. The 44,500‑m² facility expands the company’s bioprocessing production footprint in the region.

What impact do you think this new center will have on biopharma manufacturing capacity and supply chain resilience across Asia-Pacific?

MilliporeSigma opens bioprocessing production center in Daejeon, South Korea

This article was originally posted on chemengonline.com.

MilliporeSigma (Burlington, Mass.), the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced the opening of a new Asia-Pacific Bioprocessing Production Center in Daejeon, South Korea. The center represents an investment of more than €300 million, the company’s largest Life Science investment in Asia-Pacific to date. The 44,500-square-meter site expands the […]

The post MilliporeSigma opens bioprocessing production center in Daejeon, South Korea appeared first on Chemical Engineering.

Login to comment

Login
Report content
Reason Description